Abstract non disponibile

Bibliographic Details
Main Authors:	Tetsu Akimoto, Yoshiyuki Morishita, Chiharu Ito, Osamu Iimura, Sadao Tsunematsu, Yuko Watanabe, Eiji Kusano, Daisuke Nagata
Format:	Article
Language:	English
Published:	AboutScience Srl 2014-08-01
Series:	Drug Target Insights
Subjects:	febuxostat chronic kidney disease hemodialysis uric acid oxidative stress
Online Access:	https://journals.aboutscience.eu/index.php/dti/article/view/1355

Similar Items

Chronic kidney disease: the role of hyperuricemia and the possibility of urate-lowering therapy
by: M. S. Eliseev
Published: (2018-04-01)

Uric Acid in Chronic Kidney Disease: A Clinical Appraisal
by: Andrea Galassi, et al.
Published: (2016-07-01)

Identification of chronic kidney disease patient characteristics influencing the renoprotective effects of febuxostat therapy: a retrospective follow-up study
by: Akinori Yamaguchi, et al.
Published: (2017-05-01)

Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
by: Tetsu Akimoto, et al.
Published: (2014-08-01)

Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
by: Tetsu Akimoto, et al.
Published: (2014-01-01)

Uric acid, gout and cardiovascular diseases: prospects for the use of urat-lowering medications
by: M. S. Eliseev, et al.
Published: (2019-08-01)

Commentaries on the updated American College of Rheumatology guidelines for the management of gout. Urate-lowering drugs (Part 1)
by: M. S. Eliseev
Published: (2020-09-01)

Experience with febuxostat in a patient with severe disabling gout
by: M. S. Eliseev, et al.
Published: (2017-09-01)

UPDATED EULAR GUIDELINES FOR THE MANAGEMENT OF GOUT. COMMENTS ON CERTAIN ITEMS
by: M. S. Eliseev
Published: (2018-01-01)

Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study
by: Lhanoo Gunawardhana, et al.
Published: (2018-05-01)

The Predictive Value of Hyperuricemia on Renal Outcome after Contrast-Enhanced Computerized Tomography
by: Ming-Ju Wu, et al.
Published: (2019-07-01)

Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout
by: Fernando Pérez-Ruiz, et al.
Published: (2019-05-01)

Dietary Antioxidant Supplements and Uric Acid in Chronic Kidney Disease: A Review
by: Stefanos Roumeliotis, et al.
Published: (2019-08-01)

Role of Age and Uric Acid Levels on Dialysis Efficacy Among End Stage Renal Disease Patients in Saudi Arabia
by: Mohd Alaraj, et al.
Published: (2016-06-01)

Effectiveness of Drug Treatments for Lowering Uric Acid on Renal Function in Patients With Chronic Kidney Disease and Hyperuricemia: A Network Meta-Analysis of Randomized Controlled Trials
by: Xiang Liu, et al.
Published: (2021-08-01)

Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis
by: Sollip Kim, et al.
Published: (2017-09-01)

Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
by: Hangying Ying, et al.
Published: (2021-07-01)

Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
by: Hangying Ying, et al.
Published: (2021-03-01)

Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy
by: M S Eliseev, et al.
Published: (2019-05-01)

The current treatment strategy for gouty arthritis
by: M. S. Petrova, et al.
Published: (2018-09-01)

Allopurinol for prevention of progression of kidney disease with hyperuricemia
by: B.H. Santhosh Pai, et al.
Published: (2013-01-01)

Serum uric acid concentration and blood pressure level in hemodialysis patients
by: Viroj Wiwanitkit
Published: (2016-04-01)

Renal safety and urate-lowering efficacy of febuxostat in gout patients with stage 4–5 chronic kidney disease not yet on dialysis
by: Sang-Hyon Kim, et al.
Published: (2020-07-01)

Hyperuricemia and Progression of Chronic Kidney Disease: A Review from Physiology and Pathogenesis to the Role of Urate-Lowering Therapy
by: Tao Han Lee, et al.
Published: (2021-09-01)

Efficacy of different urinary uric acid indicators in patients with chronic kidney disease
by: Haochen Guan, et al.
Published: (2020-07-01)

Effects of uric acid-lowering therapy on the progression of chronic kidney disease: a systematic review and meta-analysis
by: Xuemei Liu, et al.
Published: (2018-10-01)

Uric Acid and its Role in the Progression of Chronic Kidney Disease: Do We Know Enough?
by: L.M. Savytska
Published: (2016-02-01)

Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review
by: Maria Erika G. Ramirez, et al.
Published: (2017-09-01)

Febuxsostat as a renoprotector in patients with chronic renal insufficiency
by: Z. V. Babenko
Published: (2019-02-01)

Association of uric acid and uric acid to creatinine ratio with chronic kidney disease in hypertensive patients
by: Nathalia Rabello Silva, et al.
Published: (2021-09-01)

Xanthine Oxidase Inhibitors for Improving Renal Function in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis
by: Anna Pisano, et al.
Published: (2017-10-01)

Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients
by: Ting-Ting Chung, et al.
Published: (2019-09-01)

Böbrek nakilli hastalarda rejeksiyon gelişimi için risk faktörler
by: Mustafa ERGİN, et al.
Published: (2020-03-01)

Urinary excretion of uric acid is negatively associated with albuminuria in patients with chronic kidney disease: a cross-sectional study
by: Fengqin Li, et al.
Published: (2018-04-01)

URIC ACID – HISTORY, PRESENT AND FUTURE
by: Alexandra Totan, et al.
Published: (2019-06-01)

SALIVARY URIC ACID – THE FRIEND HIDDEN BEHIND THE CURTAIN
by: Alexandra Totan, et al.
Published: (2019-09-01)

Dysfunction of natural killer cells in end-stage kidney disease on hemodialysis
by: Kei Nagai
Published: (2021-02-01)

Intradialytic Cardiovascular Exercise Training Alters Redox Status, Reduces Inflammation and Improves Physical Performance in Patients with Chronic Kidney Disease
by: Apostolos Sovatzidis, et al.
Published: (2020-09-01)

Changes in thiol/disulfide homeostasis in patients with chronic kidney disease
by: Ibrahim Solak, et al.
Published: (2020-03-01)

THE PRACTICAL VALUE OF OXIDANT-ANTIOXIDANT PARAMETERS INPATIENTS TREATED WITH HEMODIALYSIS
by: L. V. Korol, et al.
Published: (2018-03-01)